Arch Biopartners Inc. (ACHFF)
OTCMKTS · Delayed Price · Currency is USD
0.3110
-0.0090 (-2.81%)
May 5, 2026, 1:21 PM EST
Arch Biopartners Market Cap
Arch Biopartners has a market cap or net worth of $21.1 million as of May 6, 2026. Its market cap has decreased by -74.39% in one year.
Market Cap
21.10M
Enterprise Value
23.02M
Revenue
115.29K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.31
Market Cap Chart
Since January 21, 2011, Arch Biopartners's market cap has decreased from 33.63M to 21.10M, a decrease of -37.25%. That is a compound annual growth rate of -3.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 21.10M | -64.32% |
| Dec 31, 2025 | 59.13M | -32.56% |
| Dec 31, 2024 | 87.67M | 25.12% |
| Dec 29, 2023 | 70.07M | -46.02% |
| Dec 30, 2022 | 129.79M | -23.83% |
| Dec 31, 2021 | 170.40M | 138.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harvard Apparatus Regenerative Technology | 27.25M |
| Provectus Biopharmaceuticals | 24.64M |
| Anebulo Pharmaceuticals | 18.76M |
| Zeo ScientifiX | 17.89M |
| Oncotelic Therapeutics | 16.70M |
| Inhibitor Therapeutics | 15.53M |
| HOOKIPA Pharma | 15.18M |
| Galera Therapeutics | 15.11M |